Castle Biosciences (CSTL)
Provides clinician-facing molecular diagnostic tests across dermatology and gastroenterology.
$35.53
After hours+0.70 (+2.01%)
At close$34.83(−0.46%)
Something off on this page? Send us feedback.
Next report
Nov 2, 26
in 41 days
EPS estimate
−$0.38
Revenue estimate
$92.1M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Jul '26Nov '26
Reported$0.32−$0.90$0.15−$0.02−$0.08−$0.49−$0.07Pending
Estimate−$0.04−$0.08−$0.51−$0.34−$0.23−$0.49−$0.41−$0.38
Surprise+900.0%−1,025.0%+129.4%+94.1%+65.2%0.0%+82.8%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Jul '26Nov '26
Reported$86.3M$87.2M$86.2M$83.0M$87.0M$84.2M$103.5MPending
Estimate$83.9M$80.3M$68.0M$80.4M$79.9M$79.2M$86.2M$92.1M
Surprise+2.9%+8.6%+26.7%+3.3%+8.9%+6.3%+20.1%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.15 | — | — |
| Sep 2027 | −$0.17 | — | — |
| Jun 2027 | −$0.29 | — | — |
| Mar 2027 | −$0.42 | — | — |
| Dec 2026 | −$0.36 | — | — |
| Nov 2026 | −$0.38 | — | — |
| Jul 2026 | −$0.41 | −$0.07 | +82.8% |
| May 2026 | −$0.49 | −$0.49 | 0.0% |
| Feb 2026 | −$0.23 | −$0.08 | +65.2% |
| Nov 2025 | −$0.34 | −$0.02 | +94.1% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Sep 2019 | |||
| Jul 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.15 | — | — | $107.2M | — | — | — |
| Sep 2027 | −$0.17 | — | — | $105.5M | — | — | — |
| Jun 2027 | −$0.29 | — | — | $102.0M | — | — | — |
| Mar 2027 | −$0.42 | — | — | $95.5M | — | — | — |
| Dec 2026 | −$0.36 | — | — | $93.7M | — | — | — |
| Nov 2, 2026 | −$0.38 | — | — | $92.1M | — | — | — |
| Jul 30, 2026 | −$0.41 | −$0.07 | +82.8% | $86.2M | $103.5M | +20.1% | +4.5% |
| May 6, 2026 | −$0.49 | −$0.49 | 0.0% | $79.2M | $84.2M | +6.3% | −22.3% |
| Feb 26, 2026 | −$0.23 | −$0.08 | +65.2% | $79.9M | $87.0M | +8.9% | −7.3% |
| Nov 3, 2025 | −$0.34 | −$0.02 | +94.1% | $80.4M | $83.0M | +3.3% | +21.7% |
| Aug 4, 2025 | |||||||
| May 5, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 4, 2024 | |||||||
| Aug 5, 2024 | |||||||
| May 2, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 2, 2023 | |||||||
| May 3, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 2, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 9, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 8, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 8, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 11, 2020 | |||||||
| Mar 10, 2020 | |||||||
| Nov 11, 2019 | |||||||
| Sep 3, 2019 | |||||||
| Jul 26, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |